Literature DB >> 452073

Long-term plateletpheresis in the management of primary thrombocytosis.

D Goldfinger, R Thompson, C Lowe, L Kurz, G Belkin.   

Abstract

We attempted to control the platelet count of a patient with primary thrombocytosis utilizing long-term plateletpheresis therapy. The patient previously could not be controlled with chemotherapy, because of rapid development of leukopenia. Although intensive pheresis at the rate of four to five procedures per week produced rapid lowering of the patient's platelet count, continued therapy at the rate of two to three procedures a week failed to maintain these counts, and platelets gradually rose to pretreatment levels. We conclude that while plateletpheresis can produce acute lowering of elevated platelet counts, the rate of platelet production in primary thrombocytosis may be too rapid to allow for long-term control by pheresis alone, utilizing an acceptable treatment schedule of one of three procedures per week.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 452073     DOI: 10.1046/j.1537-2995.1979.19379204219.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

Review 1.  The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.

Authors:  Prajwal Boddu; Lorenzo Falchi; Chitra Hosing; Kate Newberry; Prithviraj Bose; Srdan Verstovsek
Journal:  Leuk Res       Date:  2017-03-22       Impact factor: 3.156

2.  Extreme Levels of Platelet Count in Essential Thrombocythemia: Management and Outcome, Report of Two Cases.

Authors:  Mohammad Abu-Tineh; Mohamed A Yassin
Journal:  Case Rep Oncol       Date:  2020-06-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.